Literature DB >> 18262245

Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy.

Ellen S Mandl1, C M F Dirven, D R Buis, T J Postma, W P Vandertop.   

Abstract

BACKGROUND: The purpose of the study was to evaluate the effects, frequency, and complications of repeated surgical resection for GBM relapse.
METHODS: A group of 32 patients with tumor recurrence, derived from a total of 126 consecutive patients with prior GBM, treated between 1999 and 2005 in the VU University Medical Center, Amsterdam, Netherlands, were retrospectively studied. Survival, functional status, morbidity, and mortality after starting salvage therapy for recurrent GBM were studied. Survival was analyzed using Kaplan-Meier survival curves, and log-rank statistics were used for group comparison.
RESULTS: Of the 32 patients with recurrent primary GBM, 20 received repeated surgery as salvage therapy. In 11 (55%) cases, repeated surgery was followed by CT or SRS. Nine (45%) patients receiving only repeated surgery showed significantly lower survival rates compared with the aforementioned 11 cases. The remaining 12 patients received only salvage CT or SRS and showed a significantly prolonged survival compared with the 9 cases receiving repeated surgery only. Surgical morbidity was 15%, and surgical mortality, 5%.
CONCLUSION: Despite inherent selection bias, this retrospective analysis suggests that repeated surgery for GBM relapse should only be considered in patients with severe symptoms and if additional salvage treatment can be administered postoperatively.

Entities:  

Mesh:

Year:  2008        PMID: 18262245     DOI: 10.1016/j.surneu.2007.03.043

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  40 in total

1.  Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.

Authors:  Christoph Straube; Greeshma Elpula; Jens Gempt; Julia Gerhardt; Stefanie Bette; Claus Zimmer; Friederike Schmidt-Graf; Bernhard Meyer; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-06-14       Impact factor: 3.621

2.  Novel Surgical Approaches to High-Grade Gliomas.

Authors:  Fahid Tariq Rasul; Colin Watts
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

Review 3.  Treatment options for recurrent high-grade gliomas.

Authors:  Harjus S Birk; Seunggu J Han; Nicholas A Butowski
Journal:  CNS Oncol       Date:  2016-12-21

Review 4.  Surgical management of high-grade glioma: a standard of care.

Authors:  Colin Watts
Journal:  CNS Oncol       Date:  2012-11

5.  Image guidance in malignant gliomas: a focused strategy.

Authors:  Evangelia Katsoulakis; Kathryn Beal; Yoshiya Yamada
Journal:  CNS Oncol       Date:  2012-11

6.  Benefit of tumor resection for recurrent glioblastoma.

Authors:  Johanna Quick; Florian Gessler; Stephan Dützmann; Elke Hattingen; Patrick N Harter; Lutz M Weise; Kea Franz; Volker Seifert; Christian Senft
Journal:  J Neurooncol       Date:  2014-02-15       Impact factor: 4.130

7.  Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis.

Authors:  Jan Kuhnhenn; Thomas Kowalski; Sabine Steenken; Kathrin Ostermann; Uwe Schlegel
Journal:  J Neurooncol       Date:  2012-06-29       Impact factor: 4.130

8.  Risk of ischemia in glioma surgery: comparison of first and repeat procedures.

Authors:  Stephan Dützmann; Florian Geßler; Andrea Bink; Johanna Quick; Kea Franz; Volker Seifert; Christian Senft
Journal:  J Neurooncol       Date:  2012-01-17       Impact factor: 4.130

9.  Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.

Authors:  J C Easaw; W P Mason; J Perry; N Laperrière; D D Eisenstat; R Del Maestro; K Bélanger; D Fulton; D Macdonald
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

10.  Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Marco Riva; Anna Maria Ascolese; Armando Santoro; Matteo Simonelli; Lorenzo Bello; Marta Scorsetti
Journal:  J Neurooncol       Date:  2016-11-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.